Cheng NM - Search Results

1

Potential false-positive meckel scan due to displaced kidney caused by recurrent retroperitoneal teratoma.

Su TP, Cheng NM, Chuang HC, Chen CC, Lin C. Su TP, et al. Among authors: cheng nm. Clin Nucl Med. 2014 Oct;39(10):e433-5. doi: 10.1097/RLU.0000000000000264. Clin Nucl Med. 2014. PMID: 24152649

2

False positive F-18 FDG PET/CT in neck and mediastinum lymph nodes due to anthracosis in a buccal cancer patient.

Cheng NM, Yeh TW, Ho KC, Ng SH, Hsueh C, Yen TC, Liao CT. Cheng NM, et al. Clin Nucl Med. 2011 Oct;36(10):963-4. doi: 10.1097/RLU.0b013e3182291f11. Clin Nucl Med. 2011. PMID: 21892065 No abstract available.

3

Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.

Cheng NM, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Liao CT, Lin CY, Hsu CL, Yen TC. Cheng NM, et al. Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1673-84. doi: 10.1007/s00259-012-2186-9. Epub 2012 Aug 2. Eur J Nucl Med Mol Imaging. 2012. PMID: 22854984

4

The promise and limits of PET texture analysis.

Cheng NM, Fang YH, Yen TC. Cheng NM, et al. Ann Nucl Med. 2013 Nov;27(9):867-9. doi: 10.1007/s12149-013-0759-8. Epub 2013 Aug 13. Ann Nucl Med. 2013. PMID: 23943197

5

Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.

Cheng NM, Fang YH, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Lin CY, Liao CT, Yen TC. Cheng NM, et al. J Nucl Med. 2013 Oct;54(10):1703-9. doi: 10.2967/jnumed.112.119289. Epub 2013 Sep 16. J Nucl Med. 2013. PMID: 24042030 Free article.

6

Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.

Cheng NM, Fang YH, Lee LY, Chang JT, Tsan DL, Ng SH, Wang HM, Liao CT, Yang LY, Hsu CH, Yen TC. Cheng NM, et al. Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):419-28. doi: 10.1007/s00259-014-2933-1. Epub 2014 Oct 23. Eur J Nucl Med Mol Imaging. 2015. PMID: 25339524

7

TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.

Ho KC, Fang YD, Chung HW, Liu YC, Chang JW, Hou MM, Yang CT, Cheng NM, Su TP, Yen TC. Ho KC, et al. Among authors: cheng nm. Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2155-2165. doi: 10.1007/s00259-016-3433-2. Epub 2016 Jun 3. Eur J Nucl Med Mol Imaging. 2016. PMID: 27260520

8

Prognostic Value of Tumor Heterogeneity and SUVmax of Pretreatment 18F-FDG PET/CT for Salivary Gland Carcinoma With High-Risk Histology.

Cheng NM, Hsieh CE, Liao CT, Ng SH, Wang HM, Fang YD, Chou WC, Lin CY, Yen TC. Cheng NM, et al. Clin Nucl Med. 2019 May;44(5):351-358. doi: 10.1097/RLU.0000000000002530. Clin Nucl Med. 2019. PMID: 30932974

9

Respiration-averaged CT for attenuation correction in non-small-cell lung cancer.

Cheng NM, Yu CT, Ho KC, Wu YC, Liu YC, Wang CW, Yen TC. Cheng NM, et al. Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):607-15. doi: 10.1007/s00259-008-0995-7. Epub 2008 Dec 3. Eur J Nucl Med Mol Imaging. 2009. PMID: 19050875

10

Pretreatment Primary Tumor and Nodal SUVmax Values on 18F-FDG PET/CT Images Predict Prognosis in Patients With Salivary Gland Carcinoma.

Hsieh CE, Cheng NM, Chou WC, Venkatesulu BP, Chou YC, Liao CT, Yen TC, Lin CY. Hsieh CE, et al. Among authors: cheng nm. Clin Nucl Med. 2018 Dec;43(12):869-879. doi: 10.1097/RLU.0000000000002287. Clin Nucl Med. 2018. PMID: 30273205

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters